全文获取类型
收费全文 | 696篇 |
免费 | 19篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 9篇 |
妇产科学 | 2篇 |
基础医学 | 38篇 |
口腔科学 | 4篇 |
临床医学 | 82篇 |
内科学 | 360篇 |
皮肤病学 | 26篇 |
神经病学 | 41篇 |
特种医学 | 4篇 |
外科学 | 29篇 |
综合类 | 21篇 |
预防医学 | 33篇 |
眼科学 | 1篇 |
药学 | 46篇 |
中国医学 | 13篇 |
肿瘤学 | 6篇 |
出版年
2023年 | 4篇 |
2022年 | 10篇 |
2021年 | 14篇 |
2020年 | 5篇 |
2019年 | 94篇 |
2018年 | 125篇 |
2017年 | 31篇 |
2016年 | 15篇 |
2015年 | 14篇 |
2014年 | 74篇 |
2013年 | 49篇 |
2012年 | 25篇 |
2011年 | 41篇 |
2010年 | 25篇 |
2009年 | 15篇 |
2008年 | 39篇 |
2007年 | 50篇 |
2006年 | 11篇 |
2005年 | 12篇 |
2004年 | 11篇 |
2003年 | 8篇 |
2002年 | 1篇 |
2001年 | 3篇 |
2000年 | 3篇 |
1998年 | 1篇 |
1997年 | 5篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1993年 | 3篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1985年 | 4篇 |
1984年 | 2篇 |
1983年 | 4篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1978年 | 1篇 |
排序方式: 共有716条查询结果,搜索用时 15 毫秒
1.
MOTOYOSHI NOMIZU YOSHIMASA INAGAKI TAKEYOSHI YAMASHITA AKO OHKUBO AKIRA OTAKA NOBUTAKA FUJII PETER P. ROLLER HARUAKI YAJIMA 《Chemical biology & drug design》1991,37(2):145-152
A new two-step deprotection/cleavage procedure for t-butoxycarbonyl (Boc) based solid phase peptide synthesis is reported. First the protective groups are removed from 4-(oxymethyl)-phenylacetamidomethyl (PAM) resin attached peptide with the weak hard acid, trimethylsilyl bromide-thioanisole/trifluoroacetic acid (TFA). In the second step, the peptide is cleaved from the resin with a stronger hard acid such as trimethylsilvl trifluoromethanesulfonate in TFA or with HF. The method is also shown to deformylate Nin-formyltryptophan moiety efficiently. The usefulness of this procedure for practical solid phase peptide synthesis is demonstrated by comparison with other deprotection methods in the synthesis of urotensin II and human endothelin. 相似文献
2.
Primary Prevention of Sudden Cardiac Death in Heart Failure: Will the Solution Be Shocking? 总被引:10,自引:0,他引:10
Barry F Uretsky MD Richard G Sheahan MD 《Journal of the American College of Cardiology》1997,30(7):1589-1597
Sudden cardiac death (SCD) may occur in as many as 40% of all patients who suffer from heart failure. This review describes the scope of the problem, risk factors for SCD, the effect of medications used in heart failure on SCD and the potential effect of the implantable cardioverter-defibrillator in primary prevention. 相似文献
3.
4.
5.
目的:分析乳腺癌肿瘤代谢异质性与p53基因表达和乳腺癌淋巴结转移的关系。方法:选取接受18F-FDG PET/CT检查的原发性乳腺癌患者34例,分别测定每例患者原发灶的肿瘤代谢异质因子(heterogeneity factor,HF),同时将HF与p53基因表达和淋巴结转移进行相关性分析,采用受试者工作特性曲线(area under receiver operating characteristic curve,ROC)分析HF对p53基因突变及淋巴结转移的诊断效能。结果:HF与乳腺癌p53基因表达呈弱相关性(P<0.05);HF与淋巴结转移无相关性(P>0.05)。结论:HF与乳腺癌p53基因表达具有相关性,HF对预测p53基因表达具有一定意义,然而,HF不能预测乳腺癌是否有淋巴结转移。 相似文献
6.
目的探讨血清肿瘤标志物人附睾分泌蛋白4(HE4)、癌抗原125(CA125)和卵巢癌风险预测模型(ROMA)在卵巢癌预测和诊断的应用价值。方法回顾性分析因卵巢肿瘤住院接受手术的患者118例,健康体检女性45例,检测卵巢癌组56例和卵巢良性肿瘤组62例患者及健康女性45例血清中HE4与CA125水平;计算出ROMA值联合评估患卵巢癌的风险性。结果 HE4和CA125血清水平、ROMA值:卵巢癌组分别为(334.04±168.42)pmol/L、(424.66±188.55)U/m L,93.12%;卵巢良性肿瘤组分别为(48.24±14.20)pmol/L、(1.44±6.99)U/m L,11.56%;正常对照组分别(45.89±10.01)pmol/L、(19.14±5.01)U/m L,6.2%。卵巢癌组与良性肿瘤组、正常对照组比较,3项均有统计学差异(P0.001);良性肿瘤组与正常对照组比较,除HE4外,其它2项有统计学差异(P0.01)。HE4和CA125水平、ROMA值敏感度分别为80.6%、72.5%、85.5%,特异度分别为94.5%、76.8%、89.3%,ROC曲线线下面积(AUC)分别为0.876、0.826、0.904。结论对卵巢癌诊断,单项检查HE4临床价值优于CA125。ROMA指数表明血清CA125、HE4联合检查可以更好地预测和诊断卵巢恶性肿瘤。 相似文献
7.
Xiaohui Lin Minhua Lin Maobai Liu Weiying Huang Xuekun Nie Zichun Chen Bin Zheng 《Journal of thoracic disease》2022,14(5):1588
BackgroundThe effect of empagliflozin on the cardiovascular outcome is consistent in heart failure with reduced ejection fraction (HFrEF) patients regardless of the presence or absence of diabetes. More evidence is needed regarding the cost-effectiveness of empagliflozin in HFrEF patients. This study sought to evaluate the economic outcomes of adding empagliflozin to the standard treatment for HFrEF patients from the perspective of the Chinese healthcare system, and thus to provide information for decision makers.MethodsBased on the EMPEROR-Reduced clinical trial and other published literature data, the direct medical costs and quality-adjusted life years (QALYs) of patients with HFrEF over a 15-year study period were simulated by a Markov model, and the incremental cost-effectiveness ratio (ICER) was calculated. The price of empagliflozin referred to the data released by Menet, the hospitalization expenses and utility values were derived from published studies in China. A one-way sensitivity analysis and probabilistic sensitivity analysis were conducted to evaluate the robustness of the model.ResultsThe results of the cost-effectiveness analysis showed that the cost of the combination arm was $5,220.98, with a utility of 4.86 QALYs, and the cost of the standard arm was $4,873.96, with a utility of 4.68 QALYs, which equated to an ICER of $1,893.59 per QALY gained. The subgroup analysis showed that patients with HFrEF and diabetes in empagliflozin group had a higher QALY (4.62 vs. 4.35) and a lower cost ($5,213.28 vs. $5,958.60) than standard group. The corresponding ICER for non-diabetic patients was $2,568.15 per QALY. Deterministic sensitivity analysis showed robust results. At the willingness-to-pay threshold of 3 times gross domestic product (GDP) per capita ($31,510.57), almost all of the scattered points in three scenarios were below the threshold line.ConclusionsAt a willingness-to-pay threshold of $31,510.57, adding empagliflozin to standard treatment is a very cost-effective option for HFrEF patients with or without diabetes in China. 相似文献
8.
Karen A.G. Takazaki Thiago Junqueira R. Rezende Alberto R.M. Martinez Carelis Gonzalez-Salazar Anamarli Nucci Iscia Lopes-Cendes Marcondes C. França 《Clinical neurophysiology》2018,129(11):2290-2295
Objectives
To evaluate autonomic symptoms and function in Friedreich’s Ataxia (FRDA).Methods
Twenty-eight FRDA patients and 24 controls underwent clinical/electrophysiological testing. We employed the Friedreich’s Ataxia Rating Scale (FARS) and the Scales for Outcomes in Parkinson’s Disease: Autonomic Questionnaire-SCOPA-AUT to estimate the intensity of ataxia and autonomic complaints, respectively. Cardiovagal tests and the quantitative sudomotor axonal reflex, Q-SART, were then assessed in both groups.Results
In the patient group, there were 11 men with mean age of 31.5?±?11.1?years. Mean SCOPA-AUT score was 15.1?±?8.1. Minimum RR interval at rest was shorter in the FRDA group (Median 831.3?×?724.0?ms, p?<?0.001). The 30:15 ratio, Valsalva index, E:I ratio, low and high frequency power presented no differences between patients and controls (p?>?0.05). Sweat responses were significantly reduced in patients for all sites tested (forearm 0.389?×?1.309?µL; proximal leg 0.406?×?1.107?µL; distal leg 0.491?×?1.232?µL; foot 0.265?×?0.708?µL; p value?<?0.05). Sweat volumes correlated with FARS scores.Conclusions
We found abnormal sudomotor but normal heart rate variability in FRDA. Small cholinergic post-ganglionic fibers are affected in the disease.Significance
Quantification of sudomotor function might be a biomarker for FRDA. 相似文献9.
BackgroundThe purpose of this study was to identify possible diagnostic indicators for heart failure (HF) and to investigate the function of immune cell infiltration in this pathophysiology.MethodsHF datasets from the Gene Expression Metascape database were utilized. R software was used to the identify differentially-expressed genes (DEGs) and perform functional correlation analysis. Least absolute shrinkage and selection operator (LASSO) and Boruta algorithms elimination algorithms were then employed to screen and validate the HF diagnostic variables. Finally, Single-sample Gene Set Enrichment Analysis (ssGSEA) was utilized to assess immune cell infiltration in HF tissues, and the Spearman association between gene expression and immune cell concentration was investigated.ResultsA total of 239 DEGs were screened in this study. SERPINA3 (area under the curve, AUC =0.958), FCN3 (AUC =0.972), FREM1 (AUC =0.954), and MNS1 (AUC =0.948) were identified as diagnostic factors of HF. The gene set differentiation analysis (GSVA) (R package “GSVA”) results showed that the high expression of FREM1 and MNS1 genes was involved in bile acid, fatty acid, and heme metabolism, suggesting that the core gene affects the progression of HF by regulating metabolism. Meanwhile, the high expression of FCN3 and SERPINA3 was related to xenobiotic metabolism, inflammatory response, and adipogenesis.ConclusionsGiven the importance of immune cell infiltration in the genesis and progression of HF, SERPINA3, FCN3, FREM1, and MNS1 may be used as diagnostic variables for HF. 相似文献
10.
Until recently, cardiorespiratory fitness (CRF) has been overlooked as a potential modifier of the inverse association between obesity and mortality (the so-called obesity paradox), observed in patients with known or suspected cardiovascular (CV) disease. Evidence from five observational cohort studies of 30,104 patients (87% male) with CV disease indicates that CRF significantly alters the obesity paradox. There is general agreement across studies that the obesity paradox persists among patients with low CRF, regardless of whether adiposity is assessed by body mass index, waist circumference, or percentage body fat. However, among patients with high CRF, risk of all-cause mortality is lowest for the overweight category in some, but not all, studies, suggesting that higher levels of fitness may modify the relationship between body fatness and survival in patients manifesting an obesity paradox. Further study is needed to better characterize the joint contribution of CRF and obesity on mortality in diverse populations. 相似文献